The Effect of Ginger (Zingiber officinalis) and Artichoke (Cynara cardunculus) Extract Supplementation on Functional Dyspepsia: A Randomised, Double-Blind, and Placebo-Controlled Clinical Trial
Table 3
Frequency distributions and MCA quantifications* of the primary and secondary outcomes.
T0 (baseline)
T1 (after 14 days)
T2 (after 28 days)
0
1
2
3
0
1
2
3
0
1
2
3
Functional dyspepsia (primary outcome)
S
—
—
—
—
10
26
25
4
9
15
21
20
P
—
—
—
—
26
27
8
0
29
17
13
2
Q
—
—
—
—
0
1.23
2.52
3.28
0
0.98
1.86
2.78
Epigastric fullness
S
22
5
16
22
30
21
9
5
40
16
5
4
P
12
14
13
22
14
21
17
9
17
22
12
10
Q
0
1.45
1.87
2.52
0
1.61
2.25
2.61
0
1.69
2.13
2.46
Bloating
S
30
7
11
17
37
14
12
2
46
8
9
2
P
13
17
19
12
15
24
18
4
19
20
19
3
Q
0
1.61
2.08
2.37
0
1.64
2.27
2.47
0
1.74
2.13
2.40
Early satiety
S
52
2
6
5
57
5
2
1
61
2
2
0
P
36
13
4
8
38
17
5
1
41
14
5
1
Q
0
2.24
2.14
2.14
0
2.19
2.57
2.75
0
2.42
2.75
2.91
Nausea
S
21
7
9
28
32
21
9
3
51
6
7
1
P
22
12
18
9
23
25
10
3
27
18
11
5
Q
0
1.79
2.17
2.18
0
1.67
2.39
2.59
0
1.86
2.19
2.37
Vomiting
S
61
1
2
1
62
3
0
0
63
2
0
0
P
48
9
1
3
53
6
2
0
52
7
2
0
Q
0
2.33
3.58
3.59
0
2.52
6.27
—
0
2.52
6.28
—
Epigastric pain
S
36
8
16
5
46
12
6
1
53
5
6
1
P
33
3
9
16
32
10
11
8
34
8
10
9
Q
0
0.78
1.51
2.62
0
1.25
2.14
2.96
0
1.47
1.98
2.93
S = supplementation frequencies, P = placebo frequencies, and Q = normalized modalities quantify by MCA algorithm (in bold). *MCA quantifications define scaled severity scores for each outcome.
